Revlimib and neutropenia Patient Reports February 09, 2012

Revlimib Side Effects Report #5375789-8
Revlimib side effect was reported by a Physician from UNITED STATES on June 22, 2007. Male patient, 69 years of age, was diagnosed with multiple myeloma  and was treated with Revlimib. After drug was administered, patient experienced the following side effects: disease progression, neutropenia, sepsis , thrombocytopenia. Revlimib dosage: 25 MG, QD X21 DAYS, ORAL. During the same period patient was treated with DECADRON. Patient died on 01/07/2007.